Search Results 881-890 of 19265 for hemoglobin

  1. Comparison of Bone Quality in Subjects with or without Type 2 Diabetes - Mayo Clinic

    ... hemoglobin A1c < 5.7% (28)]. Subjects with fractures only of the skull and face, hands and fingers, feet and toes, patella, and ankle, sites which are not ...

  2. Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways - Mayo Clinic

    Clinical laboratory data include: fasting plasma glucose ≥ 100mg/dL, plasma glucose of ≥ 140mg/dL two hours after a 75g glucose load, or hemoglobin A1C ≥ 5.7 ...

  3. Health and Wellness Coaching for Employees with T2D - Mayo Clinic

    an uninterrupted hemoglobin HbA1c ≥ 6.5% within a year despite standard care;; BMI of 25 or above (recorded or to be calculated) in the EMR;; have a T2D ...

  4. Regulation of Muscle Protein Phenotype in Humans with Obesity - Mayo Clinic

    - low hemoglobin or hematocrit - use of anabolic steroids or corticosteroids (within 3 months) - not classified as inactive/sedentary based on the Stanford ...

  5. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    Hemoglobin (HgB) >8.5 g/dL; Bilirubin ≤3.0 x upper limit of normal (ULN); SGOT (AST) ≤2.5 x ULN, if subject has HCC or liver metastases ≤5 x UL; SGPT (ALT) ...

  6. Osteoarthritis Clinical Trials - Mayo Clinic Research

    We will collect both non-invasive hemoglobin and conventional serum hemoglobin labs from patients postoperatively following outpatient total joint ...

  7. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL. Hemoglobin = ______;; Total bilirubin < 1.5 x upper limit of normal (ULN), or < 2.5 x ULN if patient has Gilbert syndrome or ...

  8. Blood donation frequently asked questions - Mayo Clinic

    You'll also be given a hemoglobin test. Both whole blood donation and apheresis are available, which gives you options as far as the length and frequency of ...

  9. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

    Hemoglobin ≥9.0 g/dL;; Total bilirubin ULN;; NOTE: If total bilirubin is out of range then direct bilirubin must be ≤ULN. Alanine transaminase (ALT) 2.5 x ...

  10. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    Hemoglobin >= 10 g/dL; Platelets >= 100 x 10^9/L; Total serum bilirubin =< institutional upper limit of normal (ULN); Alanine aminotransferase (ALT) and ...